Celgene Is Building An Autoimmune Empire -- And No One Is Talking About It

Image source: PublicDomainPictures.net.When it comes to Celgene (NASDAQ: CELG), investors' focus has revolved around its megablockbuster Revlimid franchise -- and for good reason. Revlimid, an oral treatment for blood cancer indicated for use in first- and second-line multiple myeloma, brought in $5.8 billion in revenue and accounted for 63% of Celgene's total sales in 2015.

Topics:  celg    revlimid   celgene   building   autoimmune empire   investors   
BING NEWS:
  • Infiltrate the Empire (Werne Village) Walkthrough
    Once you’re ready to move on, head north. Nowa will hide in the first barrel when you approach it. Wait until the coast is clear, then head northwest. Hide in the barrel shown in the screenshot above ...
    04/23/2024 - 3:15 am | View Link
  • Empire State Building honors USA Olympians and Paralympians 100 days before Summer Games
    Olympics in Paris approach, the Empire State Building recognized Team USA Olympians and Paralympians by shining red, white and blue.
    04/17/2024 - 10:32 am | View Link
  • Opinion: A real plan for Empire AI
    Empire AI must address the disruptive effects of technology on our society that we can observe today. AI or AI-related technologies have been replacing low wage workers doing mundane and repetitive ...
    04/15/2024 - 10:59 am | View Link
  • ASX Small Caps and IPO Weekly Wrap: Local markets fade despite a solid surge for gold
    The ASX 200 ended the week -0.42% lower because of reasons. Goldies won, but Utilities and Materials picked the eyes out of the rest.
    04/11/2024 - 6:48 pm | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News